无定制器械中心使用开窗/分支支架挽救失败腹主动脉瘤修复的长期结局
本研究回顾性分析2013至2025年两家无法获取定制器械的三级中心中75例因疾病进展、移植物移位或IA型内漏导致腹主动脉瘤修复失败后使用开窗/分支腔内修复(F/B-EVAR)挽救的患者。技术成功率达100%,平均随访42个月,再干预率21.0%,5年免于再干预率76.2%,总生存率84.0%,表明F/B-EVAR在无定制器械中心亦可行且中期至长期结局持久。
要点
- 无定制器械中心使用F/B-EVAR挽救失败AAA修复技术成功率达100%。
- 5年免于再干预率为76.2%,总生存率为84.0%。
- F/B-EVAR可作为开放转换的可行替代方案。
核心结论
- F/B-EVAR用于失败AAA修复的挽救治疗可行且有效,即使在没有定制器械的中心,技术成功率高且中期至长期结局持久。
研究设计与样本
- 回顾性分析两家无法获取定制器械的三级中心前瞻性维护数据库,纳入2013至2025年因失败AAA修复接受F/B-EVAR挽救的75例患者。
主要发现
- 技术成功率为100%,277根目标血管成功纳入。
- 围手术期并发症发生率为10.7%,包括无需透析的肾衰竭5.3%、截瘫1.3%和骨筋膜室综合征2.7%。
- 住院期间死亡2例(2.7%)。
- 平均随访42±37个月,21.0%需要再干预;分支主要通畅率和主要辅助通畅率分别为97.5%和99.6%。
- 51例(68.0%)出现瘤囊回缩>5 mm;Kaplan-Meier估计1年和5年免于再干预率分别为85.8%和76.2%,总生存率分别为95.7%和84.0%。
临床怎么用
- 在无定制器械的中心,F/B-EVAR可作为失败AAA修复患者开放转换的可行替代方案,适用于广泛风险谱的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Failed abdominal aortic aneurysm (AAA) repair due to disease progression, graft migration, or type IA endoleak presents a complex management challenge. Although open conversion remains the traditional treatment, fenestrated/branched endovascular aneurysm repair (F/B-EVAR) offers a less invasive alternative but is technically challenging due to added anatomic constraints and presence of previous graft material. We evaluate outcomes of F/B-EVAR for failed previous AAA repair at centers without access to custom-made devices (CMDs). METHODS: We retrospectively reviewed prospectively maintained databases of patients with failed AAA repairs rescued with F/B-EVAR between 2013 and 2025 at two tertiary centers without access to CMDs, under senior author's investigational device exemption. Primary endpoints were technical success (completion of F/B-EVAR without open conversion, target-vessel loss, or type IA/B/III endoleak), device integrity, and vessel patency. Secondary endpoints were major adverse events, mortality, and reintervention. RESULTS: Among 486 patients who underwent F/B-EVAR, 75 (15.4%) had a failed previous AAA repair. Median age was 77 years (interquartile range, 72-82), and 91.8% were male. Previous failed repairs included infrarenal EVAR (80.0%), previous open repair (14.7%), and previous FEVAR (5.3%); 48.0% had ≥1 previous reintervention. The primary indication was proximal seal failure, most commonly type IA endoleak (78.7%). Technical success was 100%. Device modification was frequently required, including main graft shortening (26.7%), distal bifurcated graft use (61.3%), inverted distal limb configuration (34.8% of bifurcated repairs), and distal graft shortening (8.7%). A total of 277 target vessels were successfully incorporated. Perioperative morbidity occurred in eight patients (10.7%), including renal failure without need for dialysis in 5.3%, paraplegia in 1.3%, and compartment syndrome in 2.7%. Two patients (2.7%) died during the index hospitalization. At a mean follow-up of 42 ± 37 months, 21.0% required reintervention. Primary and primary-assisted branch patency were 97.5% and 99.6%, respectively. Sac regression >5 mm occurred in 51 patients (68.0%). Kaplan-Meier estimated freedom from reintervention was 85.8% at 1 year and 76.2% at 5 years; with overall survival of 95.7% and 84.0%, respectively. CONCLUSIONS: F/B-EVAR for failed AAA repair is feasible and effective, even at centers without CMD, with excellent technical success and durable mid- to long-term outcomes. These findings support F/B-EVAR as a viable alternative to open conversion across a broad risk spectrum.
引用
- Hanif H, Rana MA, Chavez L, et al. Long-term outcomes of patients with failed abdominal aortic aneurysm repairs rescued using fenestrated/branched stent-grafts at centers without access to custom-made devices. J Vasc Surg. 2026. PMID: 42331149. doi:10.1016/j.jvs.2026.06.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。